Coya Therapeutics, Inc. (COYA)

Coya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.06	32.63	5.93	4.34	8.72
Cash & Short-Term Investments	31.06	32.63	5.93	4.34	8.72
Cash Growth	185.29%	449.86%	36.72%	-50.23%	-
Other Receivables	-	7.5	-	-	0
Receivables	-	7.5	-	-	0
Prepaid Expenses	4.45	1.07	1.25	0.24	0.03
Total Current Assets	35.51	41.2	7.18	4.58	8.75
Property, Plant & Equipment	0.05	0.07	0.09	0.12	-
Long-Term Deferred Charges	-	-	1.12	0.09	-
Total Assets	35.55	41.26	8.4	4.79	8.75
Accounts Payable	0.34	1.16	1.82	0.86	0.45
Accrued Expenses	1.41	2.25	2.01	0.29	-
Current Income Taxes Payable	-	0.72	-	-	-
Current Unearned Revenue	0.57	0.92	-	-	-
Total Current Liabilities	2.32	5.05	3.82	1.15	0.45
Long-Term Debt	-	-	12.97	-	-
Long-Term Unearned Revenue	1.22	0.57	-	-	-
Total Liabilities	3.54	5.63	16.79	1.15	0.45
Common Stock	0	0	0	0	0
Additional Paid-In Capital	69.83	61.5	0.68	0.47	0.24
Retained Earnings	-37.82	-25.86	-17.87	-5.62	-0.73
Comprehensive Income & Other	-	-0.01	-	-	-
Total Common Equity	32.01	35.64	-17.19	-5.15	-0.49
Shareholders' Equity	32.01	35.64	-8.39	3.64	8.3
Total Liabilities & Equity	35.55	41.26	8.4	4.79	8.75
Total Debt	-	-	12.97	-	-
Net Cash (Debt)	31.06	32.63	-7.03	4.34	8.72
Net Cash Growth	185.29%	-	-	-50.23%	-
Net Cash Per Share	2.23	3.21	-2.71	1.68	4.74
Filing Date Shares Outstanding	16.71	14.54	9.95	2.59	1.84
Total Common Shares Outstanding	15.22	14.41	2.59	2.59	1.84
Working Capital	33.19	36.14	3.36	3.44	8.3
Book Value Per Share	2.10	2.47	-6.64	-1.99	-0.27
Tangible Book Value	32.01	35.64	-17.19	-5.15	-0.49
Tangible Book Value Per Share	2.10	2.47	-6.64	-1.99	-0.27
Machinery	-	0.14	0.14	0.14	-

Source: S&P Capital IQ. Standard template. Financial Sources.